According to RxSight's latest financial reports the company's current EPS (TTM) is -HK$15.46. In 2022 the company made an earnings per share (EPS) of -HK$18.80 a decrease over its 2021 EPS that were of -HK$16.55.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -HK$15.60 | -17.06% |
2022 | -HK$18.80 | 13.65% |
2021 | -HK$16.55 | 199.31% |
2020 | -HK$5.53 |